Suppr超能文献

miR-608 通过靶向巨噬细胞移动抑制因子抑制脑胶质瘤干细胞的迁移和侵袭。

MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.

机构信息

Department of Physiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning 110122, P.R. China.

Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang, Liaoning 110122, P.R. China.

出版信息

Oncol Rep. 2016 May;35(5):2733-42. doi: 10.3892/or.2016.4652. Epub 2016 Mar 3.

Abstract

Glioma stem cells (GSCs) contribute to the malignant biological behavior of these tumors and have also been shown to be resistant to radiation and chemotherapy. Recently, a variety of microRNAs (miRNAs) has been found to present altered expression and to play an important oncogenic role or tumor-suppressive function in cancer stem cells (CSCs). microRNA-608 (miR-608) is one of the newly discovered microRNAs, and its biological functions remain unclear. Human macrophage migration inhibitory factor (MIF) is a well known oncogene associated with tumor recurrence and the poor prognosis of gliomas. In the present study, we found that miR-608 negatively regulated the gene expression of MIF at the post‑transcriptional level and plays a tumor-suppressive role by targeting MIF in GSCs. We found that miR-608 expression was significantly downregulated and the expression levels of the MIF gene and protein showed an increase in the GSCs. miR-608 overexpression significantly attenuated the proliferation, migration and invasion, and induced the apoptosis of GSCs. The dual-luciferase reporter system revealed that the 3'UTR of MIF is a direct target of miR-608, and miR-608 negatively regulates the gene expression of MIF at the post-transcriptional level by targeting its 3'UTR. Furthermore, we demonstrated that miR-608 overexpression inhibited the malignant behavior of GSCs by downregulating MIF. Western blot results showed that the inhibition of MIF resulted in the inactivation of the PI3K/AKT and JNK pathways. These results demonstrate that miR-608 acts as a potential tumor suppressor and provide insight into new therapeutic targets for malignant glioma.

摘要

神经胶质瘤干细胞(GSCs)促进了这些肿瘤的恶性生物学行为,并且已经被证明对放射治疗和化学疗法具有抗性。最近,多种 microRNA(miRNA)已被发现存在表达改变,并在癌症干细胞(CSC)中发挥重要的致癌作用或肿瘤抑制功能。miRNA-608(miR-608)是新发现的 microRNA 之一,其生物学功能尚不清楚。人巨噬细胞移动抑制因子(MIF)是一种众所周知的癌基因,与肿瘤复发和胶质瘤的不良预后相关。在本研究中,我们发现 miR-608 在后转录水平上负调控 MIF 的基因表达,并通过靶向 MIF 在 GSCs 中发挥肿瘤抑制作用。我们发现 miR-608 的表达显著下调,并且 MIF 基因和蛋白的表达水平在 GSCs 中增加。miR-608 的过表达显著减弱了 GSCs 的增殖、迁移和侵袭,并诱导了其凋亡。双荧光素酶报告系统显示,MIF 的 3'UTR 是 miR-608 的直接靶标,并且 miR-608 通过靶向其 3'UTR 在后转录水平上负调控 MIF 的基因表达。此外,我们证明 miR-608 通过下调 MIF 来抑制 GSCs 的恶性行为。Western blot 结果显示,抑制 MIF 导致 PI3K/AKT 和 JNK 通路失活。这些结果表明,miR-608 作为一种潜在的肿瘤抑制因子发挥作用,并为恶性神经胶质瘤提供了新的治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验